Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
37 Cards in this Set
- Front
- Back
four columns of anesthesia?
|
analgesia
amnesia hypnosis immobility |
|
properties of an ideal anesthetic drug?
|
-loss of consciousness smoothly and rapidly;
-prompt recovery of cognitive function after administration is discontinued; -wide margin of safety; -devoid of adverse effects |
|
how were stages of general anesthesia discovered?
|
described by Guedel for induction of diethyl ether anesthesia
|
|
stages of general anesthesia?
|
1.analgesia
2.excitement 3.surgical anesthesia 4.medullary depression |
|
characteristics of stage 1 of general anesthesia?
|
analgesia: conscious but no pain, later amnesia is produced
|
|
characteristics of stage 2 of general anesthesia?
|
excitement: delirious, may vocalize but is amnesic, respiration irregular in volume and rate, vomiting may occur if stimulated
|
|
characteristics of stage 3 of general anesthesia?
|
surgical anesthesia: apnea, analgesia, hemodynamic depression
|
|
characteristics of stage 4 of general anesthesia?
|
medullary depression: severe depression of the vasomotor and respiratory center, death rapidly ensues without support
|
|
meyer-overton rule?
|
number of anesthetic molecules dissoved at the site of anesthetic action, not the types of molecules present, cause anesthesia
|
|
unitary theory of narcosis?
|
potency of anesthetics increases with the lipid solubility
|
|
blood solubility and anesthetic drugs?
|
less blood soluble have quicker induction and recovery
|
|
lipid solubility and anesthetic drugs?
|
higher lipid solubility have higher potency
|
|
best measurement of anesthetic potency?
|
minimum alveolar concentration (at 1 atm) of an agent that produces immobility in 50% of subjects exposed to a noxious stimulus
|
|
factors that determine the uptake of volatile anesthetics depends on?
|
1.lipid solubility
2.cardiac output 3.alveolar-to-venous partial pressure difference |
|
general trends for Fa/Fi (alveolar anesthetic concentration/inspired concentration)?
|
approach to Fa/Fi = 1 is most rapid with least soluble anesthetic and slowest with most soluble anesthetic
|
|
effect of administering N2O with a second gas?
|
reduction in volume from uptake of N2O increases its concentration as well as the concentrations of all 'second' gases
|
|
cause of increase in cardiac output (if unopposed by a concomitant increase in ventilation)?
|
decrease alveolar anesthetic concentration
|
|
increase in ventilation?
|
increase alveolar anesthetic concentration
|
|
influence of age on anesthetic uptake?
|
more rapid increase in Fa/Fi
|
|
major factors that decrease MAC?
|
decreased with N2O or increased age;
increased in younger |
|
importance of diffusion hypoxia?
|
need to increase O2 as decreasing anesthesia as gas coming out will decrease O2 concentrations in alveoli
|
|
partition coefficient?
|
relative affinity of a compound for two phases and describes the partitioning of it between the two phases at equilibrium
|
|
volatile anesthetics effects on brain?
|
reduction in metabolic rate but increase in cerebral blood flow
|
|
toxicity associated with halothane and mechanism?
|
halothane hepatitis: believed to be an immune response directed againste hepatocytes
|
|
which volatile anesthetic produces highest amounts of CO?
|
desflurane
|
|
volatile anesthetics?
|
sevoflurane
desflurane isoflurane nitrous oxide halothane |
|
intravenous anesthetics?
|
etomidate
fentanyl (opioid) ketamine medazolam propofol thiopental |
|
IV anesthetics used for normal anesthesia?
|
midazolam
propofol |
|
IV anesthetics used for trauma or CHF?
|
etomidate
ketamine |
|
termination of action of thiopental?
|
redistribution
|
|
major contraindication for barbiturates?
|
prophyrias
|
|
benzodiazepine mechansim?
|
GABA-receptor agonists
|
|
time to recovery after dose or infusion of propofol?
|
fast
|
|
significance of context-sensitive half-time?
|
rapidity with which drug levels drops is directly related to time of infusion; use drugs with shorter half-times for prolonged infusion
|
|
which drugs have significantly shorter half-times?
|
etomidate
propofol ketamine |
|
propofol infusion syndrome?
|
associated with infusion at 5 mg/kg/hr or greater for >48 hours;
cardiomyopathy with acute cardiac failure, metabolic acidosis, skeletal myopathy, hyperkalemia, hepatomegaly, lipemia |
|
ketamine site of action?
|
NMDA receptor interaction;
does not interact with GABA |